Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Thursday, October 24, 2013

Conference for Healthcare Transparency and Patient Advocacy, November 1, 2013 in Lexington KY




 November 1, 2013  Healthwatch USA in Lexington Kentucky


No comments:

Post a Comment